Viewing Study NCT04873895


Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2025-12-27 @ 9:54 PM
Study NCT ID: NCT04873895
Status: TERMINATED
Last Update Posted: 2024-04-26
First Post: 2021-04-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module